相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
Pieter de Groot et al.
GUT (2020)
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Manuela Battaglia et al.
DIABETES CARE (2020)
Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial
Pieter F. de Groot et al.
DIABETOLOGIA (2020)
Isolation of Desulfovibrio spp. from human gut microbiota using a next-generation sequencing directed culture method
Y-R Chen et al.
LETTERS IN APPLIED MICROBIOLOGY (2019)
GPR31-dependent dendrite protrusion of intestinal CX3CR1+ cells by bacterial metabolites
Naoki Morita et al.
NATURE (2019)
Compartmentalized gut lymph node drainage dictates adaptive immune responses
Daria Esterhazy et al.
NATURE (2019)
Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?
Judith Aron-Wisnewsky et al.
CURRENT DIABETES REPORTS (2019)
Analysis of pancreatic beta cell specific CD4+T cells reveals a predominance of proinsulin specific cells
Gabriele Blahnik et al.
CELLULAR IMMUNOLOGY (2019)
The challenge of modulating β-cell autoimmunity in type 1 diabetes
Mark A. Atkinson et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine
Bart O. Roep et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice
Arno Hanninen et al.
GUT (2018)
Plasma lipid species at type 1 diabetes onset predict residual beta-cell function after 6 months
Anne Julie Overgaard et al.
METABOLOMICS (2018)
Cell Biology of T Cell Receptor Expression and Regulation
Andres Alcover et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors
Slobodan Culina et al.
SCIENCE IMMUNOLOGY (2018)
Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota
Silvia Pellegrini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Intestinal microbiota are involved in the immunomodulatory activities of longan polysaccharide
Jiachao Zhang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development
Hua Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study
Pieter F. de Groot et al.
PLOS ONE (2017)
Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes (vol 18, pg 552, 2017)
Eliana Marino et al.
NATURE IMMUNOLOGY (2017)
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
Ruud S. Kootte et al.
CELL METABOLISM (2017)
Pancreatic β-Cell production of CXCR3 ligands precedes diabetes onset
Susan J. Burke et al.
BIOFACTORS (2016)
A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility
Mahesh S. Desai et al.
CELL (2016)
Development and maintenance of intestinal regulatory T cells
Takeshi Tanoue et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
Aleksandar D. Kostic et al.
CELL HOST & MICROBE (2015)
A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes
Austin G. Davis-Richardson et al.
DIABETOLOGIA (2015)
Hydrogen Sulfide Promotes Tet1-and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis
Ruili Yang et al.
IMMUNITY (2015)
Cellular Mechanisms of CCL22-Mediated Attenuation of Autoimmune Diabetes
Loraine Bischoff et al.
JOURNAL OF IMMUNOLOGY (2015)
Reduction in CD4 Central Memory T-Cell Subset in Costimulation Modulator Abatacept-Treated Patients With Recent-Onset Type 1 Diabetes Is Associated With Slower C-Peptide Decline
Tihamer Orban et al.
DIABETES (2014)
Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
Tihamer Orban et al.
DIABETES CARE (2014)
Aberrant gut microbiota composition at the onset of type 1 diabetes in young children
Marcus C. de Goffau et al.
DIABETOLOGIA (2014)
Fecal Microbiota Composition Differs Between Children With β-Cell Autoimmunity and Those Without
Marcus C. de Goffau et al.
DIABETES (2013)
Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
Kevan C. Herold et al.
DIABETES (2013)
Metabolic niche of a prominent sulfate-reducing human gut bacterium
Federico E. Rey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
On the Etiology of Type 1 Diabetes A New Animal Model Signifying a Decisive Role for Bacteria Eliciting an Adverse Innate Immunity Response
Stella Korsgren et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
Anne Vrieze et al.
GASTROENTEROLOGY (2012)
Acute Gastrointestinal Infection Induces Long-Lived Microbiota-Specific T Cell Responses
Timothy W. Hand et al.
SCIENCE (2012)
Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets
Joel Montane et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
Tihamer Orban et al.
LANCET (2011)
Control of TH17 cells occurs in the small intestine
Enric Esplugues et al.
NATURE (2011)
Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Type 1 Diabetes
John M. Lachin et al.
PLOS ONE (2011)
Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
Christopher T. Brown et al.
PLOS ONE (2011)
Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice
Martin A. Kriegel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Islet inflammation and CXCL10 in recent-onset type 1 diabetes
B. O. Roep et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism
Craig Meagher et al.
DIABETES (2010)
Stability selection
Nicolai Meinshausen et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2010)
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
Li Wen et al.
NATURE (2008)
CCL4 protects from type 1 diabetes by altering islet β-cell-targeted inflammatory responses
Craig Meagher et al.
DIABETES (2007)
Hydrogen sulfide is a novel prosecretory neuromodulator in the guinea-pig and human colon
Rudolf Schicho et al.
GASTROENTEROLOGY (2006)
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
B Keymeulen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
KC Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
